Baidu
map

阿奇霉素配伍禁忌

2017-06-13 佚名 合理用药百科

阿奇霉素为第二代大环内酯药物,主要用于治疗呼吸道及生殖道感染。 可治疗多种病原体引起的儿童及成人的呼吸道感染,生殖道沙眼衣原体感染等,并被多个国家和地区的医学指南推荐作为上述感染的一线治疗药物推荐(如美国,日本,中国,美国及中国CDC)。

注射用阿奇霉素

注射用阿奇霉素适应于肺炎,盆腔炎,衣原体肺炎,军团菌病,支原体肺炎,肺炎球菌肺炎,呼吸内科,妇产科等。

将注射用阿奇霉素适量用适量注射用水充分溶解,配制成0.1g/ml,再加入至250ml或500ml的氯化钠注射液或5%葡萄糖注射液中,最终阿奇霉素浓度为1.0~2.0mg/ml,然后静脉滴注。

以下是注射用阿奇霉素的配伍禁忌:

1、与茶碱合用时能提高后者在血浆中的浓度,应注意检测血浆茶碱水平。

2、与华法林合用时应注意检查凝血酶原时间。

3、与下列药物同时使用时,建议密切观察患者:

  1)地高辛  使地高辛水平升高。

  2)麦角胺或二氢麦角胺   急性麦角毒性,症状是严重的末梢血管痉挛和感觉迟钝(触物感痛)。

  3)细胞色素P450系统代谢药  提高血清中卡马西平、特非那定、环孢素、环已巴比妥、苯妥英的水平。

4、与利福布汀合用会增加后者的毒性。

口服阿奇霉素

阿奇霉素是一种半合成大环内酯类抗生素

该药具有抗菌谱较广,口服后吸收迅速、不良反应轻、耐受性好等优点。

主要适用于慢性肺疾病并发急性感染、急性细菌性鼻窦炎、社区获得性肺炎、咽炎、扁桃体炎等。

以下是口服阿奇霉素的配伍禁忌:

1、因含铝、镁的抗酸药可降低阿奇霉素的血药浓度,必须服用时,阿奇霉素应在上述药物服用前1小时服食。

2、阿奇霉素不宜与林可霉素类抗生素,如克林霉素、林可霉素合用,因两者的作用机制基本相似,合用时药物相互竞争相似的靶位,会产生拮抗作用,也易使细菌产生耐药,甚至加重不良反应。

3、与平喘药茶碱合用时可使血内茶碱清除率下降,半衰期延长,导致后者在血浆中的浓度升高或(和)毒性反应增加,应注意监测血浆茶碱水平。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-16 小康子70

    好东西,收藏了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-14 惠映实验室

    学习了,要注意药物的相互作用。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-14 stupidox

    学习了,谢谢。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-14 189****7206

    学习了谢谢分享。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-14 蒋宇

    学习了 要警惕

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1942400, encodeId=e43d194240096, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Wed Nov 08 03:37:00 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211515, encodeId=6869211515c9, content=好东西,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep3KyYH7kyqVwUwK81ibQRkWMqRMVwerlwD2Ie9byeRp2RL9wKmLgoNwShDTdTNL8RQHfhDsAt0N9A/132, createdBy=99b61684657, createdName=小康子70, createdTime=Fri Jun 16 11:15:28 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545089, encodeId=1c52154508979, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9513684874, createdName=thinkibmz_44722598, createdTime=Thu Jun 15 10:37:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210495, encodeId=b31d2104953d, content=学习了,要注意药物的相互作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Jun 14 07:04:32 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210491, encodeId=f9072104915d, content=学习了,谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Wed Jun 14 07:01:56 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210423, encodeId=9b5421042368, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Jun 14 05:24:58 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210391, encodeId=66a3210391d4, content=学习了 要警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7SEMbIqicph9XjjB508YwgovWXrJrvXs6oQCG2x4iaUOS1ouvNLf8dRtkwfFsMN1sRUP5e5rbr7eUJPS8Gdt0aOq/0, createdBy=99cf2073595, createdName=蒋宇, createdTime=Wed Jun 14 03:03:20 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210357, encodeId=7fdd21035eb8, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jun 13 22:39:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-13 1ddf0692m34(暂无匿称)

    学习了,涨知识

    0

相关资讯

黄金搭档:654-2与阿奇霉素的巧妙运用 !

一、山莨菪碱:可提高阿奇霉素治疗肺炎的疗效1.主要机制山莨菪碱能抑制呼吸道腺体的过度分泌,减少呼吸道分泌物,从而减轻对呼吸道粘膜的刺激;抑制迷走神经兴奋性,削弱咳嗽的神经反射过程,呈现一定的镇咳作用;山莨菪碱能稳定溶酶体膜,抗自由基,减少肿瘤因子在肺、肝、心、肾组织中的表达,起到有效地防治肺损伤的作用;改善肺循环,减轻肺淤血,促进肺部啰音消失,有利于支气管肺炎、支气管炎病变的恢复。2.临床应用万政

CMAJ:阿奇霉素是否增加室性心律失常风险?

目前关于关阿奇霉素潜在的致心律失常作用的观察性研究的结果不一致。2017年4月,发表在《CMAJ》的一项巢式病例-对照研究显示,当同未使用抗生素相比,目前阿奇霉素使用与室性心律失常风险的增加相关,但是同目前阿莫西林使用相比则未显示增加风险。

阿奇霉素:三种情况要慎用!

阿奇霉素临床应用广泛。一方面,对沙眼衣原体或敏感淋球奈瑟菌所致的性传播疾病,仅需单次口服1.0g;另一方面,对一般感染,一日一次,一次0.25g,连服5日,患者依从性高;再者,与红霉素相比,阿奇霉素的胃肠道反应程度轻、发生率低。但是,作为大环内酯类抗生素,阿奇霉素也可致严重、甚至致命的不良反应。

为什么阿奇霉素和头孢不能联合用药?

和朋友们谈起抗生素的联合应用问题,见仁见智,各有各的看法和观点。有的说头孢类和阿奇联合用了很长时间,效果很好;有的人就反对说这样联用不合理,并列举教科书123条论证,常常争得面红耳赤却谁也说服不了谁。就此将抗生素的联合用药原则及相互作用总结如下,非本人一家之言,乃医药人士多年经验之积累所成,有意者可借鉴参考,请批评指正。抗生素按其作用性质可分为四类:A、繁殖期杀菌剂:有β-内酰胺类、先锋霉素族;B

J Allergy Clin Immunol Pract:非变应性鼻炎儿童的复发急性鼻窦炎的阿奇霉素预防

复发性急性鼻窦炎(RARS)是通过急性鼻窦炎的多种发作情况鉴定的,并且症状和标志完全消退。抗生素在非变应性鼻炎(NAR)儿童中预防RARS的角色还没有被调查。最近,有研究就阿奇霉素预防NAR儿童的RARS进行了评估。研究人员在患有RARS的NAR儿童(5-15岁)中设计了一个随机的、双盲的和安慰剂对照的研究。阿奇霉素(5 mg/kg/d) 3 d/wk共12个月和安慰剂分别分配到研究和对照组。排除

Baidu
map
Baidu
map
Baidu
map